Streamlining laboratory procedures, bioinformatics and integrating use of genomic data in infectious disease surveillance in Finland

Grant number: 101112962

Grant search

Key facts

  • Disease

    COVID-19, Disease X
  • Start & end year

    2023
    2027
  • Known Financial Commitments (USD)

    $1,968,911.69
  • Funder

    European Commission
  • Principal Investigator

    SAVOLAINEN-KOPRA Carita
  • Research Location

    Finland
  • Lead Research Institution

    TERVEYDEN JA HYVINVOINNIN LAITOS
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease surveillance & mapping

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

In the HERA funded project 'ÄúEnhancing Whole Genome Sequencing (WGS) and/or Reverse Transcription Polymerase Chain Reaction (RT-PCR) national infrastructures and capacities to respond to the Covid-19 pandemic in Finland'Äù national technical resources for genomic surveillance of SARS-CoV-2 and other infectious diseases were improved. The aim of the current project is to take improved technical resources into routine use. The project is divided in three work packages (WP) progressing in parallel. In WP1 Laboratory methodology and procedures we aim to develop and harmonize methodology for genetic surveillance of microbial infections including viruses and bacteria. In WP2 Public health microbiology bioinformatics in Finland we will streamline processes for genetic data analyses including data collection, transfer, storage, bioinformatical analysing and dissemination of results. In WP3 Surveillance systems we will integrate the produced and collected genetic data to surveillance systems and enhanced utilization in outbreak investigations, communication, and modelling. The Finnish Institute for Health and Welfare (THL) will be responsible for the project lead with clinical microbiology laboratories in Finland acting as associated partners. The duration of the project is 24 months.